Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 721-727

  Hartmann, Arndt ^a   Moser, Karin ^a   Kriegmair, Martin ^b   Hofstetter, Alfons ^b   Hofstaedter, Ferdinand ^a   Knuechel, Ruth ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; DIGOXIGENIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER GENETICS; CHROMOSOME 17; CHROMOSOME 9; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; ENDOSCOPY; EPITHELIUM HYPERPLASIA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PAPILLARY CARCINOMA; PHOTODYNAMICS; PRIORITY JOURNAL; UROTHELIUM;

EID: 0033030354     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65318-7     Document Type: Article

References (26)

1. Amin MB, Young RH: Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia. Semin Diagn Pathol 1997, 14:84-97
2. Kriegmair M, Baumgartner R, Knuchel R, Stepp H, Hofstadter F, Hofstetter A: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence [see comments]. J Urol 1996, 155:105-109
3. Steinbach P, Kriegmair M, Baumgartner R, Hofstadter F, Knuchel R: Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. Urology 1994, 44:676-668
4. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM: 5-Aminolevulinic acid-based photodynamic therapy: clinical research and future challenges. Cancer 1997, 79:2282-2308
5. Chatuverdi V, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B: Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene 1997, 14:2059-2070
6. Koss LG: Tumors of the urinary bladder. Atlas of Tumor Pathology. Vol. 16 (2nd series, fascicle 11). Washington, DC, Armed Forces Institute of Pathology, 1975
7. Spruck CH, Ohneseit PF, Gonzalez Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R, Dubeau L, Nichols PW, Herrman GG, Steven K, Horn T, Skinner DG, Jones PA: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994, 54:784-788
8. Dalbagni G, Presti J, Reuter V, Fair WR, Cordon Cardo C: Genetic alterations in bladder cancer [see comments]. Lancet 1993, 342: 469-471
9. Ruppert JM, Tokino K, Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 1993, 53: 5093-5095
10. Cordon Cardo C, Dalbagni G, Sarkis AS, Reuter VE Genetic alterations associated with bladder cancer. Important Adv Oncol 1994, 1:71-83
11. Simoneau AR, Spruck CH, Gonzalez Zulueta M, Gonzalgo ML, Chan MF, Tsai YC, Dean M, Steven K, Horn T, Jones PA: Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Cancer Res 1996, 56:5039-5043
12. Habuchi T, Yoshida O, Knowles MA: A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Hum Mol Genet 1997, 6:913-919
13. Strathdee CA, Duncan AM, Buchwald M: Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat Genet 1992, 1:196-198
14. Sobin LH and Wittekind: TNM Classification of malignant tumours. Fifth Edition. New York, Weinheim Wiley-Liss, 1997
15. Taylor DC, Bhagavan BS, Larsen MP, Cox JA, Epstein JI: Papillary urothelial hyperplasia. A precursor to papillary neoplasms. Am J Surg Path 1996, 20:1481-1488
16. Shepherd NS, Pfrogner BD, Coulby JN, Ackerman SL, Vaidyanathan G, Sauer RH, Balkenhol TC, Sternberg N: Preparation and screening of an arrayed human genomic library generated with the P1 cloning system. Proc Natl Acad Sci USA 1994, 91:2629-2633
17. Lee S, Rasheed S: A simple procedure for maximum yield of high-quality plasmid DNA. Biotechniques 1990, 9:676-679
18. Sauter G, Deng G, Moch H, Kerschmann R, Matsumura K, De Vries S, George T, Fuentes J, Carroll P, Mihatsch MJ, Waldman FM: Physical deletion of the p53 gene in bladder cancer: detection by fluorescence in situ hybridization. Am J Pathol 1994, 144:756-766
19. Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM: Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int J Cancer 1995, 64:99-103
20. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, 3d, Gonzalez Zulueta M, Nichols PW, Skinner DG, Jones PA: Role of chromosome 9 in human bladder cancer. Cancer Res 1993, 53:4066-4070
21. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JE, Malkowicz SB: Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 1993, 2:1407-1411
22. Gonzalez Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa M, El Baz M, Nichols PW, Gonzalgo ML, Malmstrom PU, Jones PA: High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder (published erratum appears in J Natl Cancer Inst 1995, 87:1807). J Natl Cancer Inst 1995, 87:1383-1393
23. Habuchi T, Luscombe M, Elder PA, Knowles MA: Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. Genomics 1998, 48:277-288
24. Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N: Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci USA 1992, 89:5847-5851
25. Dietmaier W, Hartmann A, Wallinger S, Heinmoeller E, Kerner T, Jauch KW, Hofstaedter F, Rueschoff J: Multiple mutation analysis in single tumor cells enabled by improved whole genome amplification. Am J Pathol 1999, 154:83-95
26. Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G: Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 1997, 57:2860-2864